![Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis](https://jcancer.org/v09/p3156/jcav09p3156g005.jpg)
Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
![Kaplan-Meier overall survival curve. The median overall survival was... | Download Scientific Diagram Kaplan-Meier overall survival curve. The median overall survival was... | Download Scientific Diagram](https://www.researchgate.net/publication/325775075/figure/fig3/AS:659702010617873@1534296624892/Kaplan-Meier-overall-survival-curve-The-median-overall-survival-was-170-days-95-CI.png)
Kaplan-Meier overall survival curve. The median overall survival was... | Download Scientific Diagram
![Validation of an assessment tool: Estimation of Postoperative Overall Survival for Gastric Cancer - European Journal of Surgical Oncology Validation of an assessment tool: Estimation of Postoperative Overall Survival for Gastric Cancer - European Journal of Surgical Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/36478a24-f62d-4c3f-bdbe-2fb076234186/gr1_lrg.jpg)
Validation of an assessment tool: Estimation of Postoperative Overall Survival for Gastric Cancer - European Journal of Surgical Oncology
![Overall survival. The Kaplan-Meier graph shows overall survival of the... | Download Scientific Diagram Overall survival. The Kaplan-Meier graph shows overall survival of the... | Download Scientific Diagram](https://www.researchgate.net/publication/312548097/figure/fig1/AS:616359859863564@1523963050372/Overall-survival-The-Kaplan-Meier-graph-shows-overall-survival-of-the-entire-patient.png)
Overall survival. The Kaplan-Meier graph shows overall survival of the... | Download Scientific Diagram
![Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study - European Journal of Cancer Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b98b535c-9b9a-45ed-bc17-fc425a85d6bb/gr1_lrg.jpg)
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study - European Journal of Cancer
![JCI Insight - Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status JCI Insight - Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status](https://df6sxcketz7bb.cloudfront.net/manuscripts/123000/123443/medium/jci.insight.123443.f2.jpg)
JCI Insight - Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status
![The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study - Clinical Genitourinary Cancer The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study - Clinical Genitourinary Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/1c8a46a0-d94c-4722-a93a-56f99d51e8e7/fx1.jpg)
The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study - Clinical Genitourinary Cancer
![Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/777aed96-2700-46bf-9ad6-0c159601b8bf/gr1a.jpg)
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG
![Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC - Journal of Hepatology Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3d9a132c-edbc-440e-a663-6fb023ee8a6a/fx1_lrg.jpg)
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC - Journal of Hepatology
![Fig. 3, [Kaplan-Meier curves showing overall survival...]. - Brain and Human Body Modeling 2020 - NCBI Bookshelf Fig. 3, [Kaplan-Meier curves showing overall survival...]. - Brain and Human Body Modeling 2020 - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK562120/bin/493434_1_En_1_Fig3_HTML.jpg)
Fig. 3, [Kaplan-Meier curves showing overall survival...]. - Brain and Human Body Modeling 2020 - NCBI Bookshelf
![Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis](https://jcancer.org/v09/p3156/jcav09p3156g008.jpg)
Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
![Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen ... Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/877ea30f-a5f1-4ae9-b000-f4d2174f1dde/gr1_lrg.jpg)
Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen ...
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis | PLOS ONE
![Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.,British Journal of Cancer - X-MOL Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.,British Journal of Cancer - X-MOL](https://xpic.x-mol.com/20190126%2F10.1038_s41416-018-0360-y.jpg)
Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.,British Journal of Cancer - X-MOL
![Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC - Journal of Thoracic Oncology Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dd6c5bd6-1cde-4ec9-b5a2-f0223bd5183c/gr1_lrg.jpg)